Table 4 Differences between the groups regarding access to clinical trials and cultural specific information
NM | FGM | SGM/TGM | p-value | |
|---|---|---|---|---|
Offered a clinical trail | 216 (50.7%) | 29 (28.4%) | 34 (56.7%) | < 0.05 |
Participated in a clinical trail | 144 (33.5%) | 16 (15.7%) | 28 (47.5%) | < 0.05 |
Offered alternative therapies | 162 (39.0%) | 37 (37.4%) | 27 (48.2%) | 0.37 |
Participated in follow-up care | 372 (91.0%) | 91 (89.2%) | 53 (94.6%) | 0.25 |
Contacted a support group | 79 (18.5%) | 11 (10.8%) | 13 (21.7%) | 0.12 |
Aware of information materials in their preferred language | 247 (60.8%) | 19 (18.6%) | 37 (69.8%) | < 0.05 |